查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1521154

生物反应器市场报告按类型（玻璃、不銹钢、一次性）、用途（实验室规模生产、中试规模生产、大规模生产）、规模（5L-20L、20L-200L、200L-1500L、1500L以上） ）、控制类型（手动、自动）和区域2024-2032

Bioreactor Market Report by Type (Glass, Stainless Steel, Single-Use), Usage (Lab-Scale Production, Pilot-Scale Production, Full-Scale Production), Scale (5L-20L, 20L-200L, 200L-1500L, Above 1500L), Control Type (Manual, Automated), and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年全球生物反应器市场规模达72亿美元。有效治疗药物的日益普及，以及预防性疫苗需求的不断增长，主要推动了市场的发展。

生物反应器市场分析：

主要市场驱动因素：包括糖尿病和癌症在内的慢性病盛行率不断上升，特别是在老年族群中，是支撑市场的因素之一。此外，各国不断成长的生物製药製造能力也是重要的成长诱导因素。

主要市场趋势：众多技术进步，包括开发一次性生物反应器（SUB），以最小的成本和能源需求优化微生物操作形成的灵活性、品质和可扩展性，是刺激整个市场的新兴趋势。

竞争格局：全球市场上一些知名的公司包括 2mag AG、bbi-biotech GmbH、Bioengineering AG、Eppendorf SE、Getinge AB、Infors AG、Merck KGaA、Pall Corporation（丹纳赫公司）、Sartorius AG、Solaris Biotechnology Srl、和赛默飞世尔科技公司等。

地理趋势：由于北美地区非常重视研发活动，因此该地区目前在市场上占有明显的主导地位。除此之外，政府机构推出的优惠政策支持可持续且具成本效益的生产方法，进一步为市场创造了正面成果。

挑战与机会：产业参与者对一致的产品品质和可扩展性的日益担忧阻碍了市场的成长。然而，先进监测和控制技术的日益整合以优化生物过程和提高可重复性将在预测期内继续推动全球市场。

生物反应器市场趋势：

一次性生物反应器的使用

一次性生物反应器（SUB）因其灵活性、成本效益、污染风险降低等优点而受到广泛欢迎。根据 IMARC 的数据，2023 年全球一次性生物反应器市场规模将达到 34 亿美元。 展望未来， IMARC Group预计到 2032 年该市场将达到 111 亿美元，从而呈现 13.8% 的成长率 (CAGR) 2024- 2032。此外，与传统的不銹钢生物反应器不同，SUB 采用一次性袋子，这有助于消除批次之间大量清洁和灭菌的需要。 2023 年 12 月，Cellexus 推出了气升式抛弃式生物反应器系统，为细胞的快速生长提供最佳的通气条件。这种温和搅拌的方法通常适用于微生物发酵和细胞培养。除此之外，主要参与者也正在生产创新的SUB设计，以满足小规模研究和大规模生产的需求，这推动了生物反应器市场的前景。例如，2024年2月，合约开发和製造组织（CDMO）药明生物宣布在爱尔兰投资约3.25亿欧元，建造约54,000公升一次性生物反应器产能的一次性场地。此外，2024 年3 月，Thermo Fisher Scientific(TM) 推出了一系列针对HyPerforma(TM) 一次性生物反应器(SUB) 产品平台的特定应用增强功能，每项增强功能均针对强化补料分批、灌注、及贴壁细胞培养物。同样，2024 年 3 月，Distek, Inc. 推出了用于哺乳动物细胞生长和重组蛋白生产的一次性生物反应器 (SUB) 系统。此外，知名公司之间的持续合作预计将在未来几年扩大市场。例如，2024年6月，Aragen Bioscience和Getinge宣布成功验证后者的一次性生产反应器（SUPR）。为此，此次合作结合了 Getinge 的创新一次性技术和 Aragen 在生物製药製造方面的专业知识。

自动化的进步

新型控制系统和自动化与生物反应器的广泛集成，透过实现对 pH、温度、溶解氧等关键参数的精确控制和即时监控，正在彻底改变生物加工。这是一个重要的生长诱导因子。例如，2023 年8 月，Repligen 公司和Sartorius 推出了一种整合式生物反应器系统，该系统包括完全相容的嵌入式XCell ATF 软体和硬体模组，提供具有整合式製程分析技术(PAT) 的预定义高阶控制配方。此外，该系统旨在为使用者提供一种简化的方法来控制细胞生长并增强灌注过程中的细胞保留，而无需使用单独的细胞保留控制塔。除此之外，2023年9月，生物技术解决方案创新者之一的Automated Control Concepts (ACC)发布了其尖端的生物反应器控制和资料平台Lab Owl，该平台允许调整多个过程参数和精确监控，从而实现一致且可重复的结果。除此之外，2023年12月，Cultzyme推出了生物反应器智慧操作奈米技术（BION）系统，配备人工智慧、硬体和云端运算，以控制生物製造过程，更有效率、以最低成本实现一致的结果。此外，对先进控制系统的需求不断增加，因为它们有助于从实验室规模无缝扩大到生产规模，这有助于确保多种生物反应器尺寸的一致性能，也增加了生物反应器市场收入。例如，2024 年 4 月，Culture Biosciences 创建了具有先进控制系统和即时监控功能的生物反应器，旨在容纳中国仓鼠卵巢 (CHO) 细胞。

永续生物加工的发展

永续性正在成为市场的关键考虑因素。知名企业正致力于最大限度地减少能源消耗和废物产生，这刺激了市场成长。 2023 年 10 月，奈良科学技术研究所和藤田大学的一组研究人员推出了一种混合电脑模拟/细胞内控制器(HISICC)，它将电脑前馈控制与转基因活细胞无缝集成，为成本降低提供了潜力。除此之外，2023 年11 月，ADM 和Solugen 建立了战略合作伙伴关係，建造约50 万平方英尺的生物製造设施，以开发分子以取代现有的基于化石燃料的材料，并扩大其低碳有机酸生产线。此外，生物反应器製造商正在投资生物反应器设计的多项创新，例如更有效率的混合和曝气系统，这提高了绿色生物加工解决方案的受欢迎程度。例如，勃林格殷格翰提供动物健康领域的生物製程技术业务，并更重视环境永续性。为此，从不断讨论和评估当前实践到优化抗原生物製造的工艺链，该公司坚定致力于最大限度地减少其环境足迹。此外，2024 年 3 月，英国研究与创新 (UKRI) 宣布开展 21 项跨部门合作，以推动全国永续生物製造的进步。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球生物反应器市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按类型

  • 玻璃
    • 市场走向
    • 市场预测
  • 不銹钢
    • 市场走向
    • 市场预测
  • 一次使用
    • 市场走向
    • 市场预测

第 7 章：市场区隔：依用途

  • 实验室规模生产
    • 市场走向
    • 市场预测
  • 中试规模生产
    • 市场走向
    • 市场预测
  • 全面生产
    • 市场走向
    • 市场预测

第 8 章：市场区隔：依规模

  • 5L-20L
    • 市场走向
    • 市场预测
  • 20L-200L
    • 市场走向
    • 市场预测
  • 200L-1500L
    • 市场走向
    • 市场预测
  • 1500L以上
    • 市场走向
    • 市场预测

第 9 章：市场区隔：按控制类型

  • 手动的
    • 市场走向
    • 市场预测
  • 自动化
    • 市场走向
    • 市场预测

第 10 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场走向
    • 市场细分：按国家/地区
    • 市场预测

第 11 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 12 章：价值链分析

第 13 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 14 章：价格分析

第15章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • 2mag AG
    • bbi-biotech GmbH
    • Bioengineering AG
    • Eppendorf SE
    • Getinge AB
    • Infors AG
    • Merck KGaA
    • Pall Corporation (Danaher Corporation)
    • Sartorius AG
    • Solaris Biotechnology Srl
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A5500

The global bioreactor market size reached US$ 7.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 18.6 Billion by 2032, exhibiting a growth rate (CAGR) of 10.9% during 2024-2032. The increasing adoption of effective treatment drugs, along with the rising need for preventive vaccines, is primarily propelling the market.

Bioreactor Market Analysis:

Major Market Drivers: The rising prevalence of chronic diseases, including diabetes and cancer, particularly among the geriatric population, is one of the factors bolstering the market. Moreover, the growing biopharmaceutical manufacturing capacities across various countries are also acting as significant growth-inducing factors.

Key Market Trends: Numerous technological advancements, including the development of single-use bioreactors (SUBs) for optimizing the flexibility, quality, and scalability of the formation of microorganism operations with minimal cost and energy requirements, are among the emerging trends stimulating the overall market.

Competitive Landscape: Some of the prominent companies in the global market include 2mag AG, bbi-biotech GmbH, Bioengineering AG, Eppendorf SE, Getinge AB, Infors AG, Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, Solaris Biotechnology Srl, and Thermo Fisher Scientific Inc., among many others.

Geographical Trends: North America currently exhibits a clear dominance in the market, on account of the region's strong emphasis on R&D activities. Apart from this, the launch of favorable policies by government bodies to support sustainable and cost-effective production methods is further creating a positive outcome for the market.

Challenges and Opportunities: The elevating concerns among industry players regarding consistent product quality and scalability are hindering the market growth. However, the increasing integration of advanced monitoring and control technologies to optimize bioprocesses and enhance reproducibility will continue to catalyze the global market over the forecasted period.

Bioreactor Market Trends:

Usage of Single-Use Bioreactors

Single-use bioreactors (SUBs) are gaining extensive popularity, owing to their benefits, such as flexibility, cost-effectiveness, reduced risk of contamination, etc. This, in turn, is stimulating the market. According to the IMARC, the global single-use bioreactors market size reached US$ 3.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 11.1 Billion by 2032, thereby exhibiting a growth rate (CAGR) of 13.8% during 2024-2032. Moreover, unlike traditional stainless-steel bioreactors, SUBs adopt disposable bags, which aids in eliminating the need for extensive cleaning and sterilization between batches. In December 2023, Cellexus introduced airlift single-use disposable bioreactor systems that offer optimal aeration for the rapid growth of cells. This method of gentle agitation is usually suitable for microbial fermentation and cell culture. Besides this, key players are also producing innovative SUB designs, catering to both small-scale research and large-scale production needs, which is fueling the bioreactor market outlook. For instance, in February 2024, the contract development and manufacturing organization (CDMO), WuXi Biologics, announced the construction of a single-use site with approximately 54,000 L of disposable bioreactor capacity via an investment of roughly €325 Million in Ireland. Additionally, in March 2024, Thermo Fisher Scientific(TM) launched a series of application-specific enhancements to the HyPerforma(TM) single-use bioreactor (SUB) product platform, each tailored to the unique requirements of intensified fed-batch, perfusion, and adherent cell cultures. Similarly, in March 2024, Distek, Inc. unveiled a single-use bioreactor (SUB) system for mammalian cell growth and recombinant protein production. Furthermore, continuous collaborations among prominent companies are projected to augment the market in the coming years. For example, in June 2024, Aragen Bioscience and Getinge announced the successful validation of the latter's single-use production reactors (SUPR). In line with this, the collaboration combined Getinge's innovative single-use technology and Aragen's expertise in biopharmaceutical manufacturing.

Advancements in Automation

The widespread integration of novel control systems and automation with bioreactors is revolutionizing bioprocessing by enabling precise control over critical parameters, such as pH, temperature, dissolved oxygen, etc., and real-time monitoring. This is acting as a significant growth-inducing factor. For instance, in August 2023, Repligen Corporation and Sartorius introduced an integrated bioreactor system that comprises a fully compatible embedded XCell ATF software and hardware module offering predefined advanced control recipes with integrated process analytical technology (PAT). Additionally, the system aims to provide users with a streamlined way to control cell growth and enhance cell retention in perfusion processes without utilizing a separate cell retention control tower. Besides this, in September 2023, Automated Control Concepts (ACC), one of the innovators in biotechnology solutions, released its cutting-edge bioreactor control and data platform, Lab Owl, that allows for adjustment of multiple process parameters and precise monitoring, resulting in consistent and reproducible outcomes. Apart from this, in December 2023, Cultzyme launched a bioreactor intelligent operative nanotechnology (BION) system equipped with AI, hardware, and cloud computing to control the biomanufacturing process and achieve consistent outcomes more efficiently and at minimal costs. Furthermore, the escalating demand for advanced control systems, as they facilitate seamless scale-up from laboratory to production scale, which aids in ensuring consistent performance across numerous bioreactor sizes, is also increasing the bioreactor market revenue. For instance, in April 2024, Culture Biosciences created bioreactors with advanced control systems and real-time monitoring capabilities designed to accommodate Chinese Hamster Ovary (CHO) cells.

Development of Sustainable Bioprocessing

Sustainability is becoming a critical consideration in the market. Prominent players are focusing on minimizing energy consumption and waste generation, which is stimulating the market growth. In October 2023, a team of researchers at the Nara Institute of Science and Technology and Fujita University introduced a hybrid in silico/in-cell controller (HISICC) that seamlessly integrates computerized feedforward control with genetically modified living cells, offering the potential for cost-effective and eco-friendly chemical and fuel production. Besides this, in November 2023, ADM and Solugen formed a strategic partnership to build an approximately 500,000-ft2 biomanufacturing facility to develop molecules to replace existing fossil fuel-based materials and scale its line of lower-carbon organic acids. Moreover, bioreactor manufacturers are investing in several innovations in bioreactor design, such as more efficient mixing and aeration systems, which is elevating the popularity of greener bioprocessing solutions. For example, Boehringer Ingelheim offers bioprocess technology operations in animal health with an improved focus on environmental sustainability. In line with this, from continuously discussing and evaluating current practices to optimizing process chains for antigenic biological manufacturing, the company is strongly committed to minimizing its environmental footprint. Additionally, in March 2024, the UK Research and Innovation (UKRI) announced 21 cross-sector collaborations to drive advancements in sustainable biomanufacturing across the country.

Global Bioreactor Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with the bioreactor market forecast at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on the type, usage, scale, and control type.

Breakup by Type:

Glass

Stainless Steel

Single-Use

Among these, single-use currently exhibit a clear dominance in the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes glass, stainless steel, and single-use. According to the report, single-use represented the largest market segmentation.

A single-use bioreactor (SUB) is widely utilized, as it is flexible and easy to use and install. Moreover, it minimizes the risk of cross-contamination, reduces labor costs, eliminates the cleaning process and validation issues, etc., thereby propelling the segment's growth. For example, in March 2024, ABEC introduced a single-use bioreactor system for cell culture production. Additionally, in February 2024, MilliporeSigma developed three Mobius(R) products that deliver improved efficiency and ease of use for biopharmaceutical manufacturing workflows. In line with this, variants include a 2000-liter mixing system for difficult-to-mix biopharm ingredients, a single-use bioreactor with an industry-leading design, and a liquid transport system for non-aseptic and aseptic substances.

Breakup by Usage:

Lab-Scale Production

Pilot-Scale Production

Full-Scale Production

Currently, pilot-scale production holds the largest bioreactor market share

The report has provided a detailed breakup and analysis of the market based on the usage. This includes lab-scale production, pilot-scale production, and full-scale production. According to the report, pilot-scale production represented the largest market segmentation.

Pilot-scale production in bioreactors serves as a crucial intermediary step between laboratory research and full-scale manufacturing in the biopharmaceutical industry. This phase allows for the optimization of bioprocesses on a scale that closely mimics commercial production, providing valuable insights into process performance, scalability, and reproducibility. Pilot-scale bioreactors typically range from 50 to 500 liters in capacity. For instance, in January 2024, San Francisco-based SciFi Foods announced the successful completion of its first commercial bioreactor facility in San Leandro, California. They are used to test and refine production parameters such as cell growth, nutrient consumption, and product yield under conditions that replicate those of large-scale operations. Additionally, pilot-scale production facilitates regulatory compliance by generating data required for process validation and quality assurance. Companies like GE Healthcare and Sartorius offer advanced pilot-scale bioreactor systems equipped with sophisticated monitoring and control technologies, enabling precise control over critical process parameters and ensuring a seamless transition to large-scale manufacturing.

Breakup by Scale:

5L-20L

20L-200L

200L-1500L

Above 1500L

The report has provided a detailed breakup and analysis of the market based on the scale. This includes 5l-20l, 20l-200l, 200l-1500l, and above 1500l.

Bioreactors are designed in various scales to meet the needs of different stages of bioprocessing, from research and development to full-scale commercial production. Small-scale bioreactors, typically ranging from 5L to 20L, are primarily used in laboratory settings for early-stage research, process development, and small-batch production. As per the bioreactor market statistics, they are essential for optimizing cell culture conditions and conducting preliminary studies. Medium-scale bioreactors, with capacities between 20L and 200L, serve as a bridge between laboratory research and pilot-scale production, allowing for the refinement of bioprocesses and scaling up experiments to a semi-industrial level. Bioreactors in the 200L to 1500L range are used for pilot-scale production, providing a realistic simulation of commercial-scale operations and facilitating the validation of production processes. Finally, bioreactors with capacities above 1500L are employed in full-scale commercial production, capable of producing large volumes of biologics, vaccines, and other biopharmaceutical products. For instance, in March 2024, Syngene International, a global contract research, development, and manufacturing organization (CRDMO), introduced a biologics facility with five 2000L single-use bioreactors in Bangalore, India.

Breakup by Control Type:

Manual

Automated

Currently, automated holds the largest bioreactor market share

The report has provided a detailed breakup and analysis of the market based on the control type. This includes manual and automated. According to the report, automated represented the largest market segmentation.

Automated bioreactors are revolutionizing bioprocessing by integrating advanced control systems that enhance precision, efficiency, and scalability. They allow for real-time monitoring and control of critical parameters, including temperature, pH, dissolved oxygen, etc. The system's automation capabilities minimize human intervention, thereby reducing the risk of contamination and errors while optimizing cell growth and product yield. For example, in May 2024, a team of researchers at Florida International University developed an automated 3D-printed bioreactor to grow bone in the lab. Additionally, biopharmaceutical manufacturers offer versatile and robust solutions to enhance productivity and maintain high standards of quality and compliance. For instance, in September 2023, Automated Control Concepts (ACC), one of the leading innovators in biotechnology solutions, announced the development of its cutting-edge bioreactor control and data platform, Lab Owl, to redefine the landscape of bioprocessing.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America currently dominates the market

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North America bioreactor market is witnessing robust growth, fueled by the region's strong emphasis on biopharmaceutical research, development, and manufacturing. Additionally, advancements in bioprocessing technologies, such as single-use bioreactors and automation, are enhancing the efficiency and scalability of biomanufacturing processes. The presence of major pharmaceutical and biotechnology companies, coupled with supportive government initiatives and funding, is further propelling the bioreactor market demand. In February 2024, Thermo Fisher Scientific expanded its manufacturing capacity at its Missouri, U.S. site to produce complex biologic treatments for a range of diseases, including cancer, autoimmune conditions, and rare disorders. Furthermore, the North America bioreactor market is poised for continued growth, driven by technological advancements and increasing biopharmaceutical production demands. For instance, in March 2023, Micro Digital Co. signed a formal contract to supply bioreactors to expand its presence in North America.

Competitive Landscape:

The bioreactor market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

2mag AG

bbi-biotech GmbH

Bioengineering AG

Eppendorf SE

Getinge AB

Infors AG

Merck KGaA

Pall Corporation (Danaher Corporation)

Sartorius AG

Solaris Biotechnology Srl

Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Bioreactor Market Recent Developments:

June 2024: Aragen Bioscience and Getinge announced the successful validation of the latter's single-use production reactors (SUPR) for large-scale recombinant antibody manufacturing.

May 2024: Multiply Labs, one of the robotics companies developing automated manufacturing systems to produce individualized drugs, and Wilson Wolf collaborated to automate Wilson Wolf's G-Rex(R) bioreactors for cell therapy manufacturing.

May 2024: A team of researchers at Florida International University introduced an automated 3D-printed bioreactor to grow bone in the lab.

Key Questions Answered in This Report

  • 1. What was the size of the global bioreactor market in 2023?
  • 2. What is the expected growth rate of the global bioreactor market during 2024-2032?
  • 3. What are the key factors driving the global bioreactor market?
  • 4. What has been the impact of COVID-19 on the global bioreactor market?
  • 5. What is the breakup of the global bioreactor market based on the type?
  • 6. What is the breakup of the global bioreactor market based on the usage?
  • 7. What is the breakup of the global bioreactor market based on the control type?
  • 8. What are the key regions in the global bioreactor market?
  • 9. Who are the key players/companies in the global bioreactor market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bioreactor Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Glass
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Stainless Steel
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Single-Use
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Usage

  • 7.1 Lab-Scale Production
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pilot-Scale Production
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Full-Scale Production
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Scale

  • 8.1 5L-20L
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 20L-200L
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 200L-1500L
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Above 1500L
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Control Type

  • 9.1 Manual
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Automated
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 2mag AG
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 bbi-biotech GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Bioengineering AG
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Eppendorf SE
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 Getinge AB
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Infors AG
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Merck KGaA
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Pall Corporation (Danaher Corporation)
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Sartorius AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Solaris Biotechnology Srl
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Bioreactor Market: Major Drivers and Challenges
  • Figure 2: Global: Bioreactor Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Bioreactor Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Bioreactor Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Bioreactor Market: Breakup by Usage (in %), 2023
  • Figure 6: Global: Bioreactor Market: Breakup by Scale (in %), 2023
  • Figure 7: Global: Bioreactor Market: Breakup by Control Type (in %), 2023
  • Figure 8: Global: Bioreactor Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Bioreactor (Glass) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Bioreactor (Glass) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Bioreactor (Stainless Steel) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Bioreactor (Stainless Steel) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Bioreactor (Single-Use) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Bioreactor (Single-Use) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Bioreactor (Lab-Scale Production) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Bioreactor (Lab-Scale Production) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Bioreactor (Pilot-Scale Production) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Bioreactor (Pilot-Scale Production) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Bioreactor (Full-Scale Production) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Bioreactor (Full-Scale Production) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Bioreactor (5L-20L) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Bioreactor (5L-20L) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Bioreactor (20L-200L) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Bioreactor (20L-200L) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Bioreactor (200L-1500L) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Bioreactor (200L-1500L) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Bioreactor (Above 1500L) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Bioreactor (Above 1500L) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Bioreactor (Manual) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Bioreactor (Manual) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Bioreactor (Automated) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Bioreactor (Automated) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: North America: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: North America: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: United States: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: United States: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Canada: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Canada: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Asia-Pacific: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Asia-Pacific: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: China: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: China: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Japan: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Japan: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: India: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: India: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: South Korea: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: South Korea: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Australia: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Australia: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Indonesia: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Indonesia: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Others: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Others: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Europe: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Europe: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Germany: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Germany: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: France: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: France: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: United Kingdom: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: United Kingdom: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Italy: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Italy: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Spain: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Spain: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Russia: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Russia: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Others: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Others: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Latin America: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Latin America: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Brazil: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Brazil: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Mexico: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Mexico: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Middle East and Africa: Bioreactor Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Middle East and Africa: Bioreactor Market: Breakup by Country (in %), 2023
  • Figure 81: Middle East and Africa: Bioreactor Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Global: Bioreactor Industry: SWOT Analysis
  • Figure 83: Global: Bioreactor Industry: Value Chain Analysis
  • Figure 84: Global: Bioreactor Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bioreactor Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bioreactor Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Bioreactor Market Forecast: Breakup by Usage (in Million US$), 2024-2032
  • Table 4: Global: Bioreactor Market Forecast: Breakup by Scale (in Million US$), 2024-2032
  • Table 5: Global: Bioreactor Market Forecast: Breakup by Control Type (in Million US$), 2024-2032
  • Table 6: Global: Bioreactor Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Bioreactor Market: Competitive Structure
  • Table 8: Global: Bioreactor Market: Key Players